Emily Johns
Overview
Explore the profile of Emily Johns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hutson L, Dan R, Brown A, Esfand S, Ruberto V, Johns E, et al.
Psychol Med
. 2024 Dec;
:1-11.
PMID: 39618324
Background: Childhood sexual abuse (CSA) and emotional maltreatment are salient risk factors for the development of major depressive disorder (MDD) in women. However, the type- and timing-specific effects of emotional...
2.
Brain encoding during perceived control as a prospective predictor of improvement in quality of life
Dan R, Brown A, Hutson L, Belleau E, Esfand S, Ruberto V, et al.
Soc Cogn Affect Neurosci
. 2024 Oct;
19(1).
PMID: 39420578
Perceived control is strongly related to mental health and well-being. Specifically, lack of perceived control has been associated with learned helplessness and stress-related disorders, such as depression and anxiety. However,...
3.
Johns E, Vossler H, Young C, Carlson M, Winer J, Younes K, et al.
Alzheimers Dement
. 2024 Jul;
20(8):5299-5310.
PMID: 38962867
Introduction: Amyloid positron emission tomography (PET) acquisition timing impacts quantification. Methods: In florbetaben (FBB) PET scans of 245 adults with and without cognitive impairment, we investigated the impact of post-injection...
4.
Younes K, Smith V, Johns E, Carlson M, Winer J, He Z, et al.
Brain Behav Immun
. 2024 May;
119:807-817.
PMID: 38710339
Understanding the psychiatric symptoms of Alzheimer s disease (AD) is crucial for advancing precision medicine and therapeutic strategies. The relationship between AD behavioral symptoms and asymmetry in spatial tau PET...
5.
Younes K, Smith V, Johns E, Carlson M, Winer J, He Z, et al.
medRxiv
. 2023 Nov;
PMID: 37986964
Understanding psychiatric symptoms in Alzheimer`s disease (AD) is crucial for advancing precision medicine and therapeutic strategies. The relationship between AD behavioral symptoms and asymmetry in spatial tau PET patterns is...
6.
Young C, Johns E, Kennedy G, Belloy M, Insel P, Greicius M, et al.
Mol Neurodegener
. 2023 Jan;
18(1):1.
PMID: 36597122
Background: APOE variants are strongly associated with abnormal amyloid aggregation and additional direct effects of APOE on tau aggregation are reported in animal and human cell models. The degree to...
7.
Willis C, Williamson M, Constantinou N, Johns E
BMJ Case Rep
. 2022 Jan;
15(1).
PMID: 35027392
An 81-year-old woman presented with neck weakness, dysarthria, dysphasia and left-sided ptosis. Myasthenia gravis (MG) was strongly suspected. Voltage gated calcium channel (VGCC) antibodies, associated with Lambert-Eaton myasthenic syndrome (LEMS),...
8.
Lorenzo-Luaces L, Johns E, Keefe J
J Med Internet Res
. 2018 Nov;
20(11):e10113.
PMID: 30413400
Background: Self-guided internet-based cognitive behavioral therapies (iCBTs) for depressive symptoms may substantially increase accessibility to mental health treatment. Despite this, questions remain as to the generalizability of the research on...
9.
Johns E, Tracey I
Rev Pain
. 2015 Nov;
3(2):2-5.
PMID: 26527574
Functional neuroimaging allows conscious reporting by human subjects to be related to changes in brain activation during painful stimulation.Brain regions thought to be involved in the perception of pain include...
10.